KR950702185A - 약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음 - Google Patents

약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음

Info

Publication number
KR950702185A
KR950702185A KR1019940704801A KR19940704801A KR950702185A KR 950702185 A KR950702185 A KR 950702185A KR 1019940704801 A KR1019940704801 A KR 1019940704801A KR 19940704801 A KR19940704801 A KR 19940704801A KR 950702185 A KR950702185 A KR 950702185A
Authority
KR
South Korea
Prior art keywords
comdounds
pyridine
pharmaceutical
full text
public disclosure
Prior art date
Application number
KR1019940704801A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950702185A publication Critical patent/KR950702185A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940704801A 1992-06-30 1994-12-29 약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음 KR950702185A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02
PCT/US1993/006234 WO1994000437A1 (en) 1992-06-30 1993-06-30 Pharmaceutical pyridine compounds

Publications (1)

Publication Number Publication Date
KR950702185A true KR950702185A (ko) 1995-06-19

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704801A KR950702185A (ko) 1992-06-30 1994-12-29 약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음

Country Status (16)

Country Link
US (1) US5990314A (ko)
EP (1) EP0649412B1 (ko)
JP (1) JP3230682B2 (ko)
KR (1) KR950702185A (ko)
CN (1) CN1108247A (ko)
AT (1) ATE231129T1 (ko)
AU (2) AU4545893A (ko)
CA (1) CA2138954A1 (ko)
DE (1) DE69332640T2 (ko)
ES (1) ES2191014T3 (ko)
IL (1) IL106156A0 (ko)
MA (1) MA22926A1 (ko)
MX (1) MX9303973A (ko)
NZ (1) NZ253967A (ko)
SI (1) SI9300349A (ko)
WO (1) WO1994000437A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT711282E (pt) 1993-07-28 2002-11-29 Aventis Pharma Ltd Compostos inibidores de pde iv e de fnt
AU1335795A (en) * 1993-12-08 1995-06-27 Smithkline Beecham Corporation Compounds
EP0732919A4 (en) * 1993-12-09 1997-05-02 Smithkline Beecham Corp DIPHENYL-2-PROPENOATE AND HOMOLOGY THEREOF FOR THE TREATMENT OF DISEASES RELATED TO LEUKOTRIA B4
EP0812194B1 (en) * 1995-03-02 2000-08-16 Smithkline Beecham Corporation Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
CA2265996A1 (en) * 1996-09-26 1998-04-02 Roger Aki Fujimoto Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU655428B2 (en) * 1990-06-07 1994-12-22 Smithkline Beecham Corporation Benzoic acid derivatives
HUT64748A (en) * 1990-06-07 1994-02-28 Smithkline Beecham Corp Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
EP0649412A1 (en) 1995-04-26
ATE231129T1 (de) 2003-02-15
EP0649412A4 (en) 1995-07-05
MA22926A1 (fr) 1994-04-01
JP3230682B2 (ja) 2001-11-19
MX9303973A (es) 1994-04-29
IL106156A0 (en) 1993-10-20
US5990314A (en) 1999-11-23
JPH07508284A (ja) 1995-09-14
AU2280797A (en) 1997-08-14
CN1108247A (zh) 1995-09-13
DE69332640T2 (de) 2003-11-06
EP0649412B1 (en) 2003-01-15
NZ253967A (en) 1996-11-26
AU707102B2 (en) 1999-07-01
DE69332640D1 (de) 2003-02-20
AU4545893A (en) 1994-01-24
SI9300349A (sl) 1993-12-31
ES2191014T3 (es) 2003-09-01
CA2138954A1 (en) 1994-01-06
WO1994000437A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
ATE243694T1 (de) 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren
DE3855501D1 (de) Chinolin-derivate als antagonisten von leukotrien d 4?
DE69318854T2 (de) Spiroazacyclischderivate als substanz p antagonisten
DE59310146D1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre Verwendung als Arzneimittel
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
CO4230097A1 (es) Piridopirimidinas sustituidas como antihipertensivos
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
KR950702185A (ko) 약제약적 피리딘 화합물(pharmaceutical pyridine comdounds)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음
ATE203519T1 (de) Chinolinderivate als antimalariamittel
NO903148L (no) Hemoreguleringspeptider.
DE69310904T2 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
DE69112573T2 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
NO924361L (no) Formazan parasittiske midler
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
NO952559L (no) N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og gastrin-relaterte mangler
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
IT1233861B (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antiinfiammatoria
TH13037A (th) " สารประกอบใหม่ "
KR920019354A (ko) 9-아미노-1,2,3,4- 테트라하이드로아크리딘-1-올 및 관련 화합물의 aids치료용 용도
ITPG950031U1 (it) Manico per cappuccio di siringa
SU1277584A1 (ru) 1,1-Ди-[2-(2-фурил)4-оксохиназолинил-3]-этилиден, проявляющий противовоспалительную и анальгезирующую активность

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application